RIT in the Headlines
RIT in the Headlines
RIT is making headlines across the national and regional media landscape. Here are the highlights from March 2021.
-
March 29, 2021
![boy swimming in a large body of water.]()
If everyone on Earth sat in the ocean at once, how much would sea level rise?
Tony Wong, assistant professor of mathematical sciences, explains volume and displacement for the "Curious Kids" series published by The Conversation.
-
March 25, 2021
![artwork of a Venn diagram titled When Grammar Mood.]()
American Sign Language Finds Its Spotlight
The New York Times interviews and features artwork by Christine Sun Kim ’02 (applied arts and sciences).
-
March 25, 2021
![a field of solar panels.]()
3 sectors that could be impacted by the battery boom
Market Watch talks to Matt Ganter, assistant research professor, about how better batteries will impact the electric vehicle, energy, and clean energy industries.
-
March 23, 2021
![glass vial of vaccine.]()
How good is the AstraZeneca vaccine – and is it really safe? 5 questions answered
The Conversation asks Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about the AstraZeneca COVID-19 vaccine.
-
March 17, 2021
![A boardwalk for traversing Sweden’s Stordalen Mire sinks in the thawing landscape.]()
How microbes in permafrost could trigger a massive carbon bomb
Nature talks to Carmody McCalley, assistant professor in the Thomas H. Gosnell School of Life Sciences, about climate models not accurately accounting for microbial activity in Arctic permafrost and Arctic lakes.
-
March 12, 2021
![Women protesting outside the White House in 1917.]()
Deaf women fought for the right to vote
Essay by Joan Naturale, reference librarian, NTID, published by The Conversation.
-
March 3, 2021
![exterior of three-story black building with glass window front.]()
RIT’s stunning new Cybersecurity Range gets $3.3M boost
University Business features IBM's donation to RIT's Global Cybersecurity Institute.
-
March 1, 2021
![box with vaccine vials.]()
This is how the Johnson & Johnson vaccine is different from Pfizer and Moderna’s shots
Fast Company talks to Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about why the efficacy of the Johnson & Johnson COVID vaccine appears to be less than the Pfizer and Moderna vaccines..
